v-Src-mediated transformation suppresses the expression of focal adhesion protein vinexin

Cancer Letters

Volumn 279, Issue 1, 2009, Pages 22-29

  Umemoto, Tsutomu ^a   Inomoto, Takahiro ^a   Ueda, Kazumitsu ^a,b   Hamaguchi, Michinari ^c   Kioka, Noriyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Focal adhesion; Transformation; v Src; Vinexin

Indexed keywords

FOCAL ADHESION KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN V SRC; PROTEIN VINEXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESIONS; GENES, SRC; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE PROTEINS; NIH 3T3 CELLS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE INHIBITORS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 67349189176     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.017     Document Type: Article

References (47)

1. De Arcangelis A., and Georges-Labouesse E. Integrin and ECM functions: roles in vertebrate development. Trends Genet. 16 (2000) 389-395
2. Dejana E. Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5 (2004) 261-270
3. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
4. Frame M.C., Fincham V.J., Carragher N.O., and Wyke J.A. v-Src's hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3 (2002) 233-245
5. Guo W., and Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5 (2004) 816-826
6. Hood J.D., and Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2 (2002) 91-100
7. Mao W., Irby R., Coppola D., Fu L., Wloch M., Turner J., Yu H., Garcia R., Jove R., and Yeatman T.J. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15 (1997) 3083-3090
8. Hynes N.E. Tyrosine kinase signalling in breast cancer. Breast Cancer Res. 2 (2000) 154-157
9. Masaki T., Okada M., Shiratori Y., Rengifo W., Matsumoto K., Maeda S., Kato N., Kanai F., Komatsu Y., Nishioka M., and Omata M. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats. Hepatology 27 (1998) 1257-1264
10. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 4 (2004) 470-480
11. Riley D., Carragher N.O., Frame M.C., and Wyke J.A. The mechanism of cell cycle regulation by v-Src. Oncogene 20 (2001) 5941-5950
12. Johnson D., Agochiya M., Samejima K., Earnshaw W., Frame M., and Wyke J. Regulation of both apoptosis and cell survival by the v-Src oncoprotein. Cell Death Differ. 7 (2000) 685-696
13. Frisch S.M., Vuori K., Ruoslahti E., and Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134 (1996) 793-799
14. Westhoff M.A., Serrels B., Fincham V.J., Frame M.C., and Carragher N.O. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol. Cell Biol. 24 (2004) 8113-8133
15. Carragher N.O., Fincham V.J., Riley D., and Frame M.C. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J. Biol. Chem. 276 (2001) 4270-4275
16. Carragher N.O., Westhoff M.A., Riley D., Potter D.A., Dutt P., Elce J.S., Greer P.A., and Frame M.C. v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation. Mol. Cell Biol. 22 (2002) 257-269
17. Kioka N., Sakata S., Kawauchi T., Amachi T., Akiyama S.K., Okazaki K., Yaen C., Yamada K.M., and Aota S. Vinexin: a novel vinculin-binding protein with multiple SH3 domains enhances actin cytoskeletal organization. J. Cell Biol. 144 (1999) 59-69
18. Chen H., Cohen D.M., Choudhury D.M., Kioka N., and Craig S.W. Spatial distribution and functional significance of activated vinculin in living cells. J. Cell Biol. 169 (2005) 459-470
19. Takahashi H., Mitsushima M., Okada N., Ito T., Aizawa S., Akahane R., Umemoto T., Ueda K., and Kioka N. Role of interaction with vinculin in recruitment of vinexins to focal adhesions. Biochem. Biophys. Res. Commun. 336 (2005) 239-246
20. Matsuyama M., Mizusaki H., Shimono A., Mukai T., Okumura K., Abe K., Shimada K., and Morohashi K. A novel isoform of vinexin, vinexin gamma, regulates Sox9 gene expression through activation of MAPK cascade in mouse fetal gonad. Genes Cells 10 (2005) 421-434
21. Paz M., Lopez-Casas P.P., and Del Mazo J. Changes in vinexin expression patterns in the mouse testis induced by developmental exposure to 17beta-estradiol. Biol. Reprod. (2007)
22. Akamatsu M., Aota S., Suwa A., Ueda K., Amachi T., Yamada K.M., Akiyama S.K., and Kioka N. Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activities. J. Biol. Chem. 274 (1999) 35933-35937
23. Suwa A., Mitsushima M., Ito T., Akamatsu M., Ueda K., Amachi T., and Kioka N. Vinexin beta regulates the anchorage dependence of ERK2 activation stimulated by epidermal growth factor. J. Biol. Chem. 277 (2002) 13053-13058
24. Mitsushima M., Suwa A., Amachi T., Ueda K., and Kioka N. Extracellular signal-regulated kinase activated by epidermal growth factor and cell adhesion interacts with and phosphorylates vinexin. J. Biol. Chem. 279 (2004) 34570-34577
25. Hough C.D., Sherman-Baust C.A., Pizer E.S., Montz F.J., Im D.D., Rosenshein N.B., Cho K.R., Riggins G.J., and Morin P.J. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 60 (2000) 6281-6287
26. Lee J.D., Yun M., Lee J.M., Choi Y., Choi Y.H., Kim J.S., Kim S.J., Kim K.S., Yang W.I., Park Y.N., Han K.H., Lee W.J., Yoo N., Lim S.M., and Park J.H. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging 31 (2004) 1621-1630
27. Mizutani K., Ito H., Iwamoto I., Morishita R., Deguchi T., Nozawa Y., Asano T., and Nagata K.I. Essential roles of ERK-mediated phosphorylation of vinexin in cell spreading, migration and anchorage-independent growth. Oncogene 26 (2007) 7122-7131
28. Mitsushima M., Ueda K., and Kioka N. Involvement of phosphatases in the anchorage-dependent regulation of ERK2 activation. Exp. Cell Res. 313 (2007) 1830-1838
29. Sohara Y., Ishiguro N., Machida K., Kurata H., Thant A.A., Senga T., Matsuda S., Kimata K., Iwata H., and Hamaguchi M. Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol. Biol. Cell 12 (2001) 1859-1868
30. Wakabayashi M., Ito T., Mitsushima M., Aizawa S., Ueda K., Amachi T., and Kioka N. Interaction of lp-dlg/KIAA0583, a membrane-associated guanylate kinase family protein, with vinexin and beta-catenin at sites of cell-cell contact. J. Biol. Chem. 278 (2003) 21709-21714
31. Kwon H.J., Yoshida M., Fukui Y., Horinouchi S., and Beppu T. Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol. Cancer Res. 52 (1992) 6926-6930
32. Sharma S.V., Agatsuma T., and Nakano H. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene 16 (1998) 2639-2645
33. Penuel E., and Martin G.S. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol. Biol. Cell 10 (1999) 1693-1703
34. Fincham V.J., James M., Frame M.C., and Winder S.J. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 19 (2000) 2911-2923
35. Kioka N., Ueda K., and Amachi T. Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein family regulating cytoskeletal organization and signal transduction. Cell Struct. Funct. 27 (2002) 1-7
36. Mitsushima M., Takahashi H., Shishido T., Ueda K., and Kioka N. Abl kinase interacts with and phosphorylates vinexin. FEBS Lett. 580 (2006) 4288-4295
37. Mitsushima M., Ueda K., and Kioka N. Vinexin beta regulates the phosphorylation of epidermal growth factor receptor on the cell surface. Genes Cells 11 (2006) 971-982
38. Soubeyran P., Barac A., Szymkiewicz I., and Dikic I. Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl. Biochem. J. 370 (2003) 29-34
39. Zhang M., Liu J., Cheng A., Deyoung S.M., Chen X., Dold L.H., and Saltiel A.R. CAP interacts with cytoskeletal proteins and regulates adhesion-mediated ERK activation and motility. EMBO J. 25 (2006) 5284-5293
40. Taieb D., Roignot J., Andre F., Garcia S., Masson B., Pierres A., Iovanna J.L., and Soubeyran P. ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity. Cancer Res. 68 (2008) 4588-4596
41. Nakamura T., Furukawa Y., Nakagawa H., Tsunoda T., Ohigashi H., Murata K., Ishikawa O., Ohgaki K., Kashimura N., Miyamoto M., Hirano S., Kondo S., Katoh H., Nakamura Y., and Katagiri T. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23 (2004) 2385-2400
42. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., and Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137 (1997) 481-492
43. Turkson J., Bowman T., Garcia R., Caldenhoven E., De Groot R.P., and Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell Biol. 18 (1998) 2545-2552
44. Yokogami K., Wakisaka S., Avruch J., and Reeves S.A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10 (2000) 47-50
45. Guertin D.A., Stevens D.M., Thoreen C.C., Burds A.A., Kalaany N.Y., Moffat J., Brown M., Fitzgerald K.J., and Sabatini D.M. Ablation in mice of the mTORC components raptor, rector, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11 (2006) 859-871
46. Carragher N.O., Fonseca B.D., and Frame M.C. Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 6 (2004) 53-73
47. Taveau M., Bourg N., Sillon G., Roudaut C., Bartoli M., and Richard I. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol. Cell Biol. 23 (2003) 9127-9135